infill

Nearly 30,000 delegates attended ESMO 2019, with many exciting and practice-changing studies presented. Here we bring you a taste of this years’ highlights, providing an insight into the plethora of recent trials which have led to significant survival and quality of life (QoL) gains for patients. PARP inhibition in ovarian…